Navigation Links
Why don't brain tumors respond to medication?
Date:9/1/2009

Malignant brain tumors often fail to respond to promising new medication. Researchers in Heidelberg have discovered a mechanism and a tumor marker for the development of this resistance. A "death receptor" can possibly provide information as to how great the chances of success are for chemotherapy. At the same time, it offers a new approach for promising brain tumor therapy.

Dr. Wolf Mller, senior consultant in the Neuropathology Department at the Institute of Pathology of Heidelberg University Hospital, and his team were able to show that certain brain tumors (astrocytomas) can deactivate a crucial protein on their cell surface, the so-called death receptor. The medication docks onto this receptor and causes the cells to die. An intact "death receptor" can thus serve as a tumor marker for whether or not a therapy has a chance of success. The study was conducted with funding from the Tumor Center of Heidelberg/Mannheim and was published in the journal Clinical Cancer Research.

Primary brain tumors that develop from brain cells, in particular their most malignant variant the glioblastoma, have a very poor prognosis. Although various kinds of therapies are attempted, patients with a glioblastoma usually die within two years of diagnosis. The researchers are thus working at high speed to become more familiar with the biology of these tumors in order to develop more efficient treatment.

"Death receptor" can be switched on and off

The researchers in Heidelberg examined various primary brain tumors (astrocytomas, which also include glioblastomas) and discovered that the gene for the death receptor DR4 was switched off in up to 75 percent of cases by what is known as "promoter methylation". This means that methyl groups accumulate at the segment of the gene that is crucial for its activity (expression). The gene's information can thus no longer be read, the gene is silenced.

The death receptor DR4 is an attracti
'/>"/>

Contact: Dr. Wolf C. Mller
Wolf.Mueller@med.uni-heidelberg.de
062-215-639-912
University Hospital Heidelberg
Source:Eurekalert

Page: 1 2

Related biology news :

1. Periodontitis and myocardial infarction: A shared genetic predisposition
2. Invasion of the brain tumors
3. HIV is a double hit to the brain
4. AIDS interferes with stem cells in the brain
5. 60 second test could help early diagnosis of common brain diseases
6. U of MN researchers discover noninvasive diagnostic tool for brain diseases
7. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
8. Influence of sex and handedness on brain is similar in capuchin monkeys and humans
9. Inside the brain of a crayfish
10. Specific brain protein required for nerve cell connections to form and function
11. Brains timing linked with timescales of the natural visual world
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... developed a new test that can distinguish between birds ... avian influenza virus or "bird flu" with those that ... step in the fight against this often fatal strain ... populations of South East Asia, particularly Indonesia and Vietnam. ... transmission to humans and the threat of a pandemic ...
(Date:10/31/2014)... 30, 2014  HITLAB SM , a healthcare ... its inaugural HITLAB Innovators Summit SM on ... HITLAB will partner with the Clinton Foundation,s Health ... ProtoHack, Columbia Business School Alumni Club of ... Engineering and Operations Research, bringing together leaders in ...
(Date:10/30/2014)... has received a $1.04 million grant from the ... and reduce osteoarthritis using a patient,s own stem ... of biodegradable polymers., Liping Tang, a bioengineering professor ... the research is primarily focused on helping soldiers ... found that if we inject microscaffolding that we,ve ...
Breaking Biology News(10 mins):New step towards eradication of H5N1 bird flu 2HITLAB Announces Inaugural HITLAB Innovators Summit 2HITLAB Announces Inaugural HITLAB Innovators Summit 3UTA researcher uses microscaffolding injections to mend cartilage, prevent osteoarthritis 2
... like cancer typically destroy nasty malignant cells, while ... in synthetic biology, researchers are designing molecules intelligent ... cells alone. "We basically design molecules that actually ... of the cellular state before delivering the therapeutic ...
... 1996 marked the beginning of a revolution in biological and ... by now the number of characterised species is approaching 1000, ... a few years away mapping the genetic evolution of ... able to identify the genetic causes of human disease and ...
... , A mutual epidemiological relationship between aggressive periodontitis and ... at the universities of Kiel, Dresden, Amsterdam and Bonn have ... on chromosome 9, which maps to a genetic region that ... latest edition of the specialist journal PLoS Genetics . ...
Cached Biology News:Engineers create intelligent molecules that seek-and-destroy diseased cells 2Engineers create intelligent molecules that seek-and-destroy diseased cells 3Genetic differences between yeasts greater than those between humans and chimpanzees 2
(Date:10/31/2014)... Caustic soda is utilized in the production of zeolites, sodium ... lead in the global caustic soda market, followed by the ... in the USA, Germany, Brazil and Canada, is currently the ... of output and production capacities. , The global caustic soda ... year in the years ahead. The APAC region is the ...
(Date:10/31/2014)... Lawrence, MA (PRWEB) October 30, 2014 ... from Latin America were hosted by Charm Sciences ... October. During their week in the US, the ... chemical residue control, hygiene management, and process verification, ... state-of-the-art facility. , This was the first visit ...
(Date:10/31/2014)... (PRWEB) October 31, 2014 Following the ... a free learning webinar to introduce its new product ... directors and biostatisticians. , Launched in September, Formedix On ... suite of clinical trial automation tools. For the first ... web browser. And by introducing Formations – a revolutionary ...
(Date:10/31/2014)... The report "Dairy Alternative (Beverage) ... Flavored, Sweetened, Unsweetened), Channel (Supermarket, Health Store, Pharmacy, ... Forecast to 2018," defines and segments the dairy ... of revenue and volume for plant-based dairy alternative ... reach $14 Billion by 2018 with the Asia-Pacific ...
Breaking Biology Technology:China to Dominate Caustic Soda Market Through 2018, Says Merchant Research & Consulting in Its New Study 2Charm Sciences Hosts Executives from Latin America for Dairy Safety Executive Seminar 2Formedix to Introduce "Revolutionary" Clinical Trial Automation Software with Learning Webinar 2Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 2Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 3Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 4
... are pleased to release the third in a ... , This third Podcast titled "Commercialization ... crucial issues around how nanotechnology can be taken ... commercial outcomes. , Dr Peter Binks, CEO of ...
... 7 Dendreon Corporation (Nasdaq:,DNDN) today announced that ... position of senior vice president of clinical affairs ... with over a decade of oncology,drug development and ... was instrumental to the filing of the company,s ...
... in the Department of Physics & Engineering ... with colleagues from the University of California, ... authored the article, High-frequency single-photon source with ... December 2007 issue of Nature Photonics ( ...
Cached Biology Technology:Commercialization of nanotechnology 2Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer 2Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer 3Professor Strauf's research is Nature Photonics’ cover article 2
... Ambion's custom siRNA service provides the premium ... silencing research. Custom siRNAs can be readily ... base target sequence, or by providing the ... out Ambion's Silencer Validated and Silencer Pre-designed ...
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
Human TGF-beta RIIb Affinity Purified Polyclonal Ab...
Biology Products: